PECAM1 and neoplasm: Moreover, quantification of CD31 staining between different groups showed that Pirfenidone treatment did not affect the total number of blood vessels (Figure 1I), suggesting that Pirfenidone can improve perfusion without affecting tumor angiogenesis.